Polymorphisms at the osteoprotegerin and interleukin-6 genes in relation to first-ever stroke

Cerebrovascular Diseases

Volumn 24, Issue 5, 2007, Pages 418-425

  Strand, Magnus ^a   Söderström, Ingegerd ^a   Wiklund, Per Gunnar ^a   Hallmans, Göran ^a   Weinehall, Lars ^a   Söderberg, Stefan ^a   Olsson, Tommy ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetics; Interleukin 6; Intracerebral hemorrhage; Ischemic stroke; Osteoprotegerin; Polymorphism

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHY; HUMAN; HYPERTENSION; INTERLEUKIN 6 GENE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OSTEOPROTEGERIN GENE; PRIORITY JOURNAL; RISK FACTOR; SEX; STROKE; UNIVARIATE ANALYSIS;

ADULT; AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; OSTEOPROTEGERIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; SWEDEN;

EID: 35548973491     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108431     Document Type: Article

References (45)

1. Stegmayr B, Asplund K: Stroke in Northern Sweden. Scand J Public Health Suppl 2003;61:60-69.
2. Mendelsohn ME: Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 2002;90:3F-6F.
3. Vliegenthart R, Hollander M, Breteler MM, van der Kuip DA, Hofman A, Oudkerk M, Witteman JC: Stroke is associated with coronary calcification as detected by electron-beam CT: The Rotterdam Coronary Calcification Study. Stroke 2002;33:462-465.
4. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M: Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:978-983.
5. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA: Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 2002;87:1062-1067.
6. Saika M, Inoue D, Kido S, Matsumoto T: 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 2001;142:2205-2212.
7. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth TB: Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev 2004;25:629-672.
8. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC: Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000;20:1926-1931.
9. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-1268.
10. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM: Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem 2000;275:20959-20962.
11. Sattler AM, Schoppet M, Schaefer JR, Hofbauer LC: Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. Calcif Tissue Int 2004;74:103-106.
12. Riggs BL: The mechanisms of estrogen regulation of bone resorption. J Clin Invest 2000;106:1203-1204.
13. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 1990;265:621-636.
14. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A: Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6:315-325.
15. Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR: Association between low bone density and stroke in elderly women: the study of osteoporotic fractures. Stroke 1993;24:940-946.
16. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL: Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999;140:4367-4370.
17. Hofbauer LC, Schoppet M, Schuller P, Viereck V, Christ M: Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women. Clin Endocrinol (Oxf) 2004;60:214-219.
18. Hofbauer LC, Schoppet M: Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 2001;358:257-259.
19. Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC, Schaefer JR: Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab 2004;89:3764-3768.
20. Brandstrom H, Stiger F, Lind L, Kahan T, Melhus H, Kindmark A: A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. Biochem Biophys Res Commun 2002;293:13-17.
21. Brandstrom H, Stiger F, Kahan T, Melhus H, Nystrom F, Ohman KP, Malmqvist K, Lind L, Kindmark A: A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients: The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). Blood Press 2004;13:152-157.
22. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ: The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001;22:2243-2252.
23. Pola R, Flex A, Gaetani E, Pola P, Bernabei R: The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population. J Hum Hypertens 2002;16:637-640.
24. Revilla M, Obach V, Cervera A, Davalos A, Castillo J, Chamorro A: A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 2002;324:29-32.
25. Wynne F, Drummond F, O'Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA: Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcif Tissue Int 2002;71:26-35.
26. Hofbauer LC, Schoppet M: Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease. J Clin Endocrinol Metab 2002;87:4078-4079.
27. Chung HW, Seo JS, Hur SE, Kim HL, Kim JY, Jung JH, Kim LH, Park BL, Shin HD: Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 2003;48:243-248.
28. Garnero P, Borel O, Sornay-Rendu E, Duboeuf F, Jeffery R, Woo P, Delmas PD: Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: The OFELY study. Bone 2002;31:43-50.
29. Stegmayr B, Lundberg V, Asplund K: The events registration and survey procedures in the Northern Sweden MONICA project. Scand J Public Health Suppl 2003;61:9-17.
30. Asplund K, Tuomilehto J, Stegmayr B, Wester PO, Tunstall-Pedoe H: Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl 1988;728:26-39.
31. Morinaga T, Nakagawa N, Yasuda H, Tsuda E, Higashio K: Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis- inhibitory factor. Eur J Biochem 1998; 254: 685-691.
32. Inouye S, Soberon X, Franceschini T, Nakamura K, Itakura K, Inouye M: Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc Natl Acad Sci USA 1982;79:3438-3441.
33. Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL: The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int 2005;16:1519-1524.
34. Price PA, June HH, Buckley JR, Williamson MK: Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001;21:1610-1616.
35. Kavurma MM, Bhindi R, Lowe HC, Chesterman C, Khachigian LM: Vessel wall apoptosis and atherosclerotic plaque instability. J Thromb Haemost 2005;3:465-472.
36. Pentimalli L, Modesti A, Vignati A, Marchese E, Albanese A, Di Rocco F, Coletti A, Di Nardo P, Fantini C, Tirpakova B, Maira G: Role of apoptosis in intracranial aneurysm rupture. J Neurosurg 2004;101:1018-1025.
37. Fisher CM: Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971;30:536-550.
38. Vinters HV, Natte R, Maat-Schieman ML, van Duinen SG, Hegeman-Kleinn I, Welling-Graafland C, Haan J, Roos RA: Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, dutch type (HCHWA-D). Acta Neuropathol (Berl) 1998;95:235-244.
39. Moran CS, McCann M, Karan M, Norman P, Ketheesan N, Golledge J: Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 2005;111:3119-3125.
40. Browner WS, Lui LY, Cummings SR: Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 2001;86:631-637.
41. Guldiken B, Guldiken S, Turgut B, Turgut N, Demir M, Celik Y, Arikan E, Tugrul A: Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. Thromb Res 2007; 24: Epub ahead of print.
42. Kase CS, Mohr JP, Caplan LR: Intracerebral Hemorrhage in Stroke. Pathophysiology, Diagnosis, and Treatment, ed 4. New York, Livingstone, 2004, pp 327-376.
43. Khosla S, Arrighi HM, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL: Correlates of osteoprotegerin levels in women and men. Osteoporos Int 2002;13:394-399.
44. Hunt JL, Fairman R, Mitchell ME, Carpenter JP, Golden M, Khalapyan T, Wolfe M, Neschis D, Milner R, Scoll B, Cusack A, Mohler ER 3rd: Bone formation in carotid plaques: a clinicopathological study. Stroke 2002;33:1214-1219.
45. Wallin R, Wajih N, Greenwood GT, Sane DC: Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 2001;21:274-301.